Eric Adler's Restricted Stock Vesting and Sale at Lexeo Therapeutics, Inc.

Eric Adler, an officer at Lexeo Therapeutics, Inc., has reported the vesting and subsequent sale of restricted stock. On October 15, 2025, Adler acquired 3,382 shares of common stock through restricted stock vesting as part of his compensation. These shares were then sold on October 17, 2025, with an aggregate market value of $30,242.18. The sale included an amount necessary to cover a tax obligation resulting from the settlement of the vested equity award distribution. Additionally, Adler had previously sold 608 shares of common stock on August 18, 2025, for $2,838.27. The transactions were facilitated by Fidelity Brokerage Services LLC.